Recent changes to national guidelines made former and current smokers eligible for lung cancer screening, but a new study by a University of Wisconsin School of Medicine and Public Health radiologist shows they did little to close the gap between people of color and white...
The CDC's committee of vaccine experts is scheduled to meet Friday to discuss the authorization before the head of the agency can sign off and let the shots begin. By Cecilia Smith-Schoenwalder, U.S. News The Food and Drug Administration on Friday authorized emergency use of Pfizer and...
Alexander disease is a progressive and rare neurological disorder with no cure or standard course of treatment. But a new study led by researchers at the University of Wisconsin–Madison involving a rat model of the disease offers a potential treatment for the typically fatal condition....
A mother's personal journey to find a clinical trial for her child's rare disease and how she navigated through the challenges. ...
The recent approval of a COVID-19 vaccine for children ages 5 to 11 years old opens the possibility of vaccinating the last large remaining segment of the population, according to doctors. ...
On Sept. 9, President Biden issued an executive order requiring COVID-19 vaccination for all federal contractors. UW–Madison currently holds federal contracts. In order to comply with the broad scope of the order, all employees must provide proof of vaccination or receive a medical or religious accommodation exempting them...
The KidCOVE phase three clinical trial at the University of Wisconsin School of Medicine and Public Health, which is evaluating the safety and effectiveness of the Moderna COVID-19 vaccine in children, has shifted focus to kids 6 months to 5-years-old. In August, enrollment for kids...
The University of Wisconsin Center for Rare Diseases has been selected as a National Organization for Rare Disorders (NORD) Rare Disease Center of Excellence. UW–Madison School of Medicine and Public Health The UW Center for Rare Diseases, a new joint collaboration between the Division of Genetics and Metabolism...
It's the question on many Americans' minds: Should I get a booster shot? And if so, when's the best time?...
By Ed Miseta, Clinical Leader There are 400 million people worldwide who are impacted by more than 7,000 identifiable rare diseases. While individual rare diseases are uncommon, approximately 5% of the world’s population suffers from one. For many of those patients, travelling to a clinic to...
